Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?

被引:12
|
作者
Jhund, Pardeep S. [1 ]
Tavazzi, Luigi [2 ,3 ,4 ]
机构
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[2] ES Hlth Sci Fdn, GVM Care & Res, Maria Cecilia Hosp, Cotignola, Italy
[3] Univ Ferrara, Dept Cardiol, Ferrara, Italy
[4] Univ Ferrara, LTTA Ctr, Ferrara, Italy
关键词
EUROPEAN-SOCIETY; AGE INSIGHTS; TRENDS; HOSPITALIZATION; EFFICACY; SAFETY; STATEMENT; MORTALITY; SURVIVAL;
D O I
10.1002/ejhf.529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:500 / 502
页数:3
相关论文
共 50 条
  • [21] Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure
    Loncar, Goran
    Garfias-Veitl, Tania
    Valentova, Miroslava
    Vatic, Mirela
    Lainscak, Mitja
    Obradovic, Danilo
    Dschietzig, Thomas Bernd
    Doehner, Wolfram
    Jankowska, Ewa A.
    Anker, Stefan D.
    von Haehling, Stephan
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (05) : 714 - 723
  • [22] Co-morbidities and heart failure related therapies: do they contribute to anabolic deficiencies in men with systolic heart failure?
    Kalicinska, E.
    Wojtas, K.
    Majda, J.
    Doehner, W.
    Von Haehling, S.
    Banasiak, W.
    Ponikowska, B.
    Anker, S. D.
    Ponikowski, P.
    Jankowska, E. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S115 - S115
  • [23] THE ASSOCIATION OF CO-MEDICATIONS AND CO-MORBIDITIES AND RISK OF DEMENTIA, IN PATIENTS WITH CHRONIC HEART FAILURE
    Agarwal, S. J.
    Johnson, M. L.
    VALUE IN HEALTH, 2009, 12 (03) : A141 - A141
  • [24] Prevalence and prognostic impact of co-morbidities in heart failure: data from the Slovenian national heart failure registry
    Vrckovnik, M. Pusnik
    Jug, B.
    Marolt, A.
    Kosuta, D.
    Hodoscek, L. M.
    Mulej, M.
    Ravnikar, T.
    Pusnik, C. S.
    Valentincic, M.
    Cuderman, T. Vizintin
    Lainscak, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 68 - 68
  • [25] The benefits of angiotensin receptor blockers in patients with chronic heart failure and multiple co-morbidities
    Erdmann, E
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2005, 6 : S11 - S12
  • [26] Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
    Michalska-Kasiczak, Marta
    Bielecka-Dabrowa, Agata
    von Haehling, Stephan
    Anker, Stefan D.
    Rysz, Jacek
    Banach, Maciej
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (04) : 890 - 909
  • [27] Performance of a multisensor implantable defibrillator algorithm for heart failure monitoring related to co-morbidities
    Santobuono, Vincenzo Ezio
    Favale, Stefano
    D'Onofrio, Antonio
    Manzo, Michele
    Calo, Leonardo
    Bertini, Matteo
    Savarese, Gianluca
    Santini, Luca
    Dello Russo, Antonio
    Lavalle, Carlo
    Viscusi, Miguel
    Amellone, Claudia
    Calvanese, Raimondo
    Arena, Giuseppe
    Pangallo, Antonio
    Rapacciuolo, Antonio
    Porcelli, Daniele
    Campari, Monica
    Valsecchi, Sergio
    Guaricci, Andrea Igoren
    ESC HEART FAILURE, 2023, 10 (04): : 2469 - 2478
  • [28] The Interaction Effect of Cardiac and Noncardiac Co-morbidities on Mortality Rates in Patients With Heart Failure
    Villadsen, Peter Ryom
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    Schmidt, Morten
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 179 : 51 - 57
  • [29] Galectin-3 in daily routine heart failure care: relationship with co-morbidities
    Meijers, W. C.
    Kobold, A. C. Muller
    Van Der Wal, M.
    Van Veldhuisen, D. J.
    De Boer, R. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 407 - 407
  • [30] Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapy
    Lorenzo, Christian J.
    Conte, Jorge, I
    Villasmil, Ricardo J.
    Abdelal, Qassem K.
    Pierce, Derek
    Wiese-Rometsch, Wilhelmine
    Garcia-Fernandez, Joel A.
    ESC HEART FAILURE, 2022, 9 (04): : 2538 - 2547